Company: Amgen Inc.
Job title: Senior Principal Scientist
Biomarker Insights from KRAS P.G12C-Mutated Subjects Treated with Sotorasib in Codebreak 100 9:30 am
Baseline biomarker subgroup associations with response in NSCLC subjects 2-year follow-up assessing biomarker correlates for NSCLC subjects deriving long-term benefit from sotorasib treatment Analysis of acquired mutations NSCLC and CRC to treatment to inform rational combo therapyRead more
day: Day One